MedPath

Remote Interrogation in Rural Emergency Departments

Phase 4
Withdrawn
Conditions
Heart Disease
Cardiovascular Disease
Heart Failure
Arrhythmias, Cardiac
Interventions
Device: Unpaired remote monitoring transmitter
Registration Number
NCT02421549
Lead Sponsor
Abbott Medical Devices
Brief Summary

A retrospective, multi-center, proof-of-concept study to evaluate the use of remote monitoring in rural emergency departments to decrease time to treatment decision for pacemaker and defibrillator patients using the St Jude Medical Merlin@home transmitter. The purpose of the study is to determine if utilization of remote monitoring technology in a rural emergency department may improve patient care.

Up to 10 rural ED sites will enroll a total of 200 patients. One hundred patients will be in the remote monitoring group comprised of patients with SJM devices compatible with the unpaired transmitter and 100 patients will be in the usual medical care group comprised of patients with SJM devices that are not compatible with the unpaired transmitter or that have a competitor's device.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Presents to Emergency Department with an implanted pacemaker or defibrillator.
  2. Are 18 years of age or older.
  3. Are willing and able to provide informed consent for study participation.
  4. Are willing and able to complete a 30-60 day follow up phone call.
Exclusion Criteria
  1. Are unwilling to provide written informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interrogation with unpaired remote monitoring transmitterUnpaired remote monitoring transmitterInterrogation with unpaired remote monitoring transmitter Interrogation with an unpaired remote monitoring transmitter for devices that are compatible.
Primary Outcome Measures
NameTimeMethod
Time to Clinical Specialist Treatment Decision1 day

ED check in time to time of clinical specialist treatment decision.

Secondary Outcome Measures
NameTimeMethod
Health Care Utilization RateWithin 30 days of initial ED visit

Device related hospitalizations, ED visits and unscheduled office visits/urgent care visits within 30 days of the initial ED visit.

Trial Locations

Locations (1)

New Mexico Heart Institute

🇺🇸

Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath